[quote]Informed people? Unlike you, I back up my words with references:[/quote]
False. I read through your steaming pile of verbiage and could not find anything to back up your claim that men should consume a maximum of 150 mg calcium per day. You also did not provide a justification for taking a product with such horribly imbalanced tocopherols.
[quote]
BTW, niacinamide is the most active form of B3 in the blood the form you mention are for people with cholesterol problems. Ideal, total cholesterol should be 180 to 199!:[/quote]
Niacinamide counteracts the beneficial effects of resveratrol, as anyone who has been paying attention here knows.
J Biol Chem. 2002 Nov 22;277(47):45099-107. Epub 2002 Sep 23.
Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1.
Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA.
Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.
The Saccharomyces cerevisiae Sir2 protein is an NAD(+)-dependent histone deacetylase that plays a critical role in transcriptional silencing, genome stability, and longevity. A human homologue of Sir2, SIRT1, regulates the activity of the p53 tumor suppressor and inhibits apoptosis. The Sir2 deacetylation reaction generates two products: O-acetyl-ADP-ribose and nicotinamide, a precursor of nicotinic acid and a form of niacin/vitamin B(3). We show here that nicotinamide strongly inhibits yeast silencing, increases rDNA recombination, and shortens replicative life span to that of a sir2 mutant. Nicotinamide abolishes silencing and leads to an eventual delocalization of Sir2 even in G(1)-arrested cells, demonstrating that silent heterochromatin requires continual Sir2 activity. We show that physiological concentrations of nicotinamide noncompetitively inhibit both Sir2 and SIRT1 in vitro. The degree of inhibition by nicotinamide (IC(50) < 50 microm) is equal to or better than the most effective known synthetic inhibitors of this class of proteins. We propose a model whereby nicotinamide inhibits deacetylation by binding to a conserved pocket adjacent to NAD(+), thereby blocking NAD(+) hydrolysis. We discuss the possibility that nicotinamide is a physiologically relevant regulator of Sir2 enzymes.
PMID: 12297502
[quote]
I advise supplement companies[/quote]
That's not something to be bragging about. The vast majority are giving their multivitamin customers an increased risk of cancer by depleting their gamma tocopherol levels. To say nothing of other stupid formulation mistakes.
[quote]
Your simply assuming form of selenium found in Broccoli is better but that is your opinion not based on studies.[/quote]
False. SeMC is the most effective selenium compound.
Nutr Cancer. 2001;40(1):12-7.
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
Medina D, Thompson H, Ganther H, Ip C.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA. dmedina@bcm.tmc.edu
Selenium compounds have attracted renewed interest as chemopreventive agents for human cancer on the basis of the pioneering intervention study by Clark and co-workers. The rodent mammary gland has been used extensively as a model for examining the chemopreventive activities of inorganic and organic selenium compounds. This review summarizes the rationale and results for use of a new organic selenium compound, Se-methylselenocysteine, which exhibits greater efficacy as a chemopreventive agent than several previously used selenium compounds in experimental models of breast cancer and has potential for use in human populations.
PMID: 11799917
http://breast-cancer...ontent/7/5/R699"In the mammary tumor model, MSC is more efficacious than the most extensively studied selenoamino acids in animal models."
http://jn.nutrition....ull/128/11/1845"We found that both selenobetaine and Se-methylselenocysteine were more efficacious than either selenite or selenomethionine in cancer chemoprevention in the range of 1-3 ppm Se"
[quote]Multi-Basics 3 has vanadium, manganese, and copper all potentially harmful.[/quote]
Not at the small doses provided.
[quote]It's short on vitamin D3 at 1,000IU should be 2,000IU's. Unless, a baby under 12 months then 1,000IU's of D3 daily:[/quote]
That depends on the individual. 1000 IU is enough to get me well into LEF's desired range. But 2000 IU is not enough for many people. Since so many people will need more than 2000 IU and be taking extra D anyway, why force those who need just 1000 IU to take unnecessary D?
[quote]Doesn't have the most active of B12 Methylcobalamin which lowers plasma homocysteine levels by encouraging methylation like folate and resveratrol does. Regular B12 being cyanocobalmin has trace amounts of cyanide that the government considers safe like fluoride and mercury dental fillings. But, only fools believe it![/quote]
Methylcobalamin should be taken sublingually to avoid the liver converting it into a different form.
The body is perfectly capable of handling the traces of cyanide found in B12 supplements. Do you have evidence to the contrary?
[quote]
Your multi also has the wrong form of vitamin K2 (MK-4) which should be the most active and benefical form MK-7 from Natto at 45mcg to 100mcg daily.[/quote]
Yet another falsehood. MK-7 is a bacterial form of K2 while MK-4 is what mammals make for themselves. Your body will try to convert MK-7 to MK-4, so save it the trouble. And since you seem vulnerable to peer pressure, I'll add that MK-4 is what the Japanese use clinically.
J Bone Miner Metab. 1999;17(1):23-9.
Effect of vitamin K2 (menaquinone-7) in fermented soybean (natto) on bone loss in ovariectomized rats.
Yamaguchi M, Taguchi H, Gao YH, Igarashi A, Tsukamoto Y.
Laboratory of Endocrinology and Molecular Metabolism, Graduate School of Nutritional Sciences, University of Shizuoka, Japan.
The effect of dietary vitamin K2 (menaquinone-7) on bone loss in ovariectomized (OVX) rats was investigated. OVX rats were freely given experimental diets containing menaquinone-4 (MK-4; 12mg/100g diet) or menaquinone-7 (MK-7; 18.1mg/100g diet) for 24 days; MK-4 and MK-7 were equal in molar concentrations. This feeding caused a remarkable increase of MK-4 and MK-7 concentrations in the serum and femur of OVX rats. OVX-induced decrease in the femoral dry weight and femoral calcium content was prevented by the feeding of dietary MK-4 or NK-7. In separate experiments, OVX rats were freely given experimental diets containing the fermented soybean (natto; including 9.4 microg MK-7/100g diet) without or with added MK-7 (37.6 microg/100g diet) for 77 days. Feeding produced a significant elevation of MK-4 and MK-7 concentrations in the serum of OVX rats.
In this case, a significant increase in the femoral MK-4 content was observed but MK-7 was not detected in the femoral tissues. OVX-induced decreases in the femoral dry weight and femoral calcium content were significantly prevented by the feeding of diets containing natto with MK-7 added (37.6 microg/100g diets). This study demonstrates that the intake of dietary MK-7 has a preventive effect on bone loss caused by OVX. This effect may be partly caused by MK-4, which is formed by degradation of MK-7.
PMID: 10084398
Nippon Rinsho. 2006 Sep;64(9):1639-43.
[Active vitamin D and vitamin K as therapeutic agents for osteoporosis]
[Article in Japanese]
Katagiri H.
Department of Orthopaedic Surgery, Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University.
Active vitamin D has been most widely used in Japan for the treatment of osteoporosis. However, clinical evidence for its efficacy as an anti-osteoporotic drug is scarce in terms of fracture prevention. Recent reports suggest that active vitamin D may prevent fracture not only through enhancement of intestinal calcium absorption but also by improving bone quality and/or strength independently of bone mass and by improving neuromuscular function to reduce the number of fall. Low serum concentrations of vitamin K have been reported in patients with osteoporosis, and serum osteocalcin appears to be undercarboxylated in these individuals, a process dependent on vitamin K. Undercarboxylated osteocalcin is also a significant risk for hip fracture. Clinical studies in Japan suggest that menatetrenone (vitamin K2) reduces skeletal losses and, in a small randomized clinical trial, it reduced the rate of vertebral fractures. Menatetrenone is currently used in Japan, the Republic of Korea and Thailand.
PMID: 16972672
[quote]Only has 1.8mg of boron should have 3mg[/quote]
It puts you at above average consumption, without even counting what you're getting from food. Why do we need an extra 1.2 mg?
[quote]Has the potentially harmful Chromium picolinate form rather than the safe life entending niacin bound ChromeMate.[/quote]
Picolinate is only harmful to cells in petri dishes. Under physiological conditions no harm has been found.
[quote]
Your multi has No ORAC rating. Americans are way low on optimal antioxidant consumption. FDA now recommends as of 2005 that Americans intake 7000 ORAC daily. The antioxidant equal to about 12 full fruit servings daily.[/quote]
Phytochemicals are best taken separately, so you can make your own choices. In multis they are usually present in small doses and are mere label padding, as in your product. For instance, the 10 mg green tea extract is an insult. The only redeeming feature is that the small dose won't interfere with mineral absorption.
[quote]Has only 11mg of zinc should be a full 15mg,[/quote]
http://books.nap.edu...=10026&page=442"The Recommended Dietary Allowance (RDA) for adults is 8 mg/day for women and 11 mg/day for men."
[quote]9. Have 99mg of Potassium Glycinate.[/quote]
Are you a homeopath?
[quote]IDEALLY, A MULTIVITAMIN WOULD HAVE 1,000MCG OF ACTUAL FOLATE NOT FOLIC ACID[/quote]
Am J Clin Nutr. 2007 Feb;85(2):465-73.
Bioavailability of food folates is 80% of that of folic acid.
Winkels RM, Brouwer IA, Siebelink E, Katan MB, Verhoef P.
Wageningen Centre for Food Sciences, Wageningen, Netherlands. renate.winkels@wur.nl
BACKGROUND: The bioavailability of natural food folates is lower than that of synthetic folic acid, but no agreement exists as to the extent of the difference. OBJECTIVE: In a 4-wk dietary intervention study, we determined the aggregate bioavailability of food folates from fruit, vegetables, and liver relative to that of folic acid. DESIGN: Seventy-two healthy adults were randomly divided into 4 treatment groups. Group A (n = 29) received a high-folate diet with 369 mug food folate/d and a placebo capsule; groups B, C, and D (n = 14 or 15) received a low-folate diet with 73 microg food folate/d and folic acid capsules. These capsules contained 92 microg folic acid/d for group B, 191 microg for group C, and 289 microg for group D. In addition, all 72 subjects daily ingested a capsule with 58 microg [(13)C(11)]-labeled folic acid. We measured the percentage of [(13)C(11)]-labeled folate in plasma folate at the end of the intervention and ascertained the changes in serum folate concentrations over the 4 wk of the intervention. RESULTS: Bioavailability of food folate relative to that of folic acid was 78% (95% CI: 48%, 108%) according to [(13)C(11)]-labeled folate and 85% (52%, 118%) according to changes in serum folate concentrations. CONCLUSIONS: The aggregate bioavailability of folates from fruit, vegetables, and liver is approximately 80% of that of folic acid. The consumption of a diet rich in food folate can improve the folate status of a population more efficiently than is generally assumed.
PMID: 17284745